Booster vaccine for Omicron variant gets emergency use approval
The booster vaccine GEMCOVAC®-OM, developed to provide immunity against the Omicron variant of Covid-19, has received approval from the regulator Drug Control General of India (DCGI) for emergency use.
The booster vaccine GEMCOVAC®-OM, developed to provide immunity against the Omicron variant of Covid-19, has received approval from the regulator Drug Control General of India (DCGI) for emergency use.
The mRNA-based vaccine was developed using the indigenous platform technology by Gennova Biopharmaceuticals Ltd. and supported under the Mission COVID Suraksha, implemented by Biotechnology Industry Research Assistance Council (BIRAC), said a Ministry of Science and Technology release.
It is a thermostable vaccine, which does not require ultra-cold chain infrastructure used for other approved mRNA-based vaccines, making it easy for deployment across the country.
"It is delivered intra-dermally using a needle-free injection device system. When administered intradermally in participants as a booster, it generated significantly higher immune responses.
The clinical outcome demonstrates the need for variant-specific vaccines for desired immune response," the release said.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.